Influence of Polymers on Nucleation and Growth Kinetics of Pharmaceuticals
Crystallization Strategies the Quest for Increased Yield and Chiral Purity
Optimal Form Screening and Selection by Controlled Crystallization
Solvent Selection in Pharmaceutical Crystallisation Process Development
Revealing Shapes: Particle Morphology Hints Impurity Rejection Capability during API Crystallization
Linking Solution Chemistry to Crystallization
Viedma Ripening and Temperature Cycling: Two Robust Deracemization Methods
Accurate Measurement and Validation of Solubility Data for Polymorphic Compounds
Growing X-ray Quality Single Crystals
Crystallization Monitoring with Raman Spectroscopy
The Use of Simulation Tools for Crystallisation Process Development
Post Rationalisation of Disorder, Metastable Polymorphs and Extreme Crystallisation Conditions
Measuring Solubility & Crystallization Behaviour
Chiral Resolution and Deracemization Through Co-crystallization
Chirality in Pharmaceutical Compounds and Absolute Configuration Determination
Crystallization Screenings: a Practical Overview
Secondary Nucleation through a single crystal seeding approach
Particle Size Control during Recrystallization and Scale-up
